Democrats At It Again, Fighting for Power, Not Consumers, With The Impeachment Threats.
By Scott Shields - Contributing Writer Capitol Times Media - Scott is also the
Co-Founder of a Consumer Protection Cryptography Company established in
2018
Ralph Nader built the consumer protection movement from outside the system — a lone
lawyer with a suitcase full of documents, pressing both parties to defend ordinary people
against concentrated corporate power. No one would have predicted that the tradition's
most consequential twenty-first-century chapter would be written by a billionaire real
estate developer turned Republican president. But look at the record, and above all at the
personnel: Donald Trump's decision to hand the Department of Health and Human
Services to Robert F. Kennedy Jr., a man who learned public-interest advocacy at Ralph
Nader's elbow, may be the clearest return of Nader-style consumerism to actual governing
power in half a century. And the response from the opposition has been telling: not a
competing consumer agenda, but a campaign to remove the advocate himself.
The Kennedy Connection
To understand why the Kennedy appointment matters, you have to understand its lineage.
Robert F. Kennedy Jr. spent decades as exactly the kind of lawyer Nader pioneered: an
environmental litigator who sued polluters directly. At Riverkeeper and the Pace
Environmental Litigation Clinic, he won landmark settlements forcing the cleanup of the
Hudson River and pioneered the use of citizen suits to hold corporate polluters
accountable. He spent years battling the chemical, agricultural, and pharmaceutical
industries he believed were harming the public, often against fierce resistance from his
own political tribe.
And his inspiration, by his own account, was Ralph Nader. Kennedy called Nader his "friend
and hero" and, as those who knew his career described it, a mentor. The two men shared a
conviction that both major parties had grown deaf to questions of corporate accountability
— and that somebody had to force the issue.
Their sharpest disagreement was instructive. In a New York Times op-ed on August 10,
2000, Kennedy pleaded with Nader to abandon his third-party run: "a vote for Mr. Nader is a
vote for Mr. Bush." Nader, principled to a fault, refused — and Kennedy warned publicly,
right up to Election Day, that Nader's candidacy "could draw enough votes in certain key
states from Al Gore to give the entire election to George W. Bush." He watched the
consequences with frustration for a generation.In 2024, history handed him the mirror-image of that choice. Mounting his own outsider
campaign on the same anti-corporate-consolidation themes Nader had raised, Kennedy
initially refused to bow out, "Americans shouldn't be forced to choose the least of two
evils," he argued, in words Nader himself could have spoken. But in August 2024 he made
the choice he had begged Nader to make: he suspended his campaign, endorsed Donald
Trump, and asked for something no Nader-style purist had ever secured, a seat inside the
government itself.
"Go Wild on Health"
Trump's response was unlike anything any modern president had offered a consumer
advocate. "For too long, Americans have been crushed by the industrial food complex and
drug companies," Trump said in announcing Kennedy as his choice to run HHS, promising
to let him "go wild on health." Critics treated it as curiosity. It was closer to a transfer of
power.
Consider what that transfer has produced, under Trump's authority, through Kennedy's
execution:
• Phasing out petroleum-based synthetic dyes. In April 2025, HHS and the FDA
launched a national initiative to phase out eight petroleum-based synthetic dyes
from the American food supply, establishing a national standard and timeline for
transitioning to natural alternatives — as the FDA noted, ingredients food
companies already use in Europe and Canada. The initiative catalyzed concrete
commitments: General Mills to remove certified colors from its U.S. cereals and
school foods by summer 2026, Nestlé to eliminate FD&C colors from its entire U.S.
portfolio by mid-2026, Conagra's phased removal from frozen foods, and dozens of
ice-cream producers — representing over 90 percent of ice cream sold in the U.S. —
agreeing to strip artificial colors by 2028. Consumer Reports, the organization
Nader's movement helped inspire, greeted the push with a demand for more: an
enforceable ban, not just voluntary pledges. Even the argument over means is a
consumer-movement argument.
• Pressuring industry face to face. Kennedy summoned the CEOs of PepsiCo, Kraft
Heinz, General Mills, Tyson Foods, WK Kellogg, and J.M. Smucker to HHS and told
them, in effect, to remove "the worst ingredients" — or the agency would act. That is
the Nader method updated: investigate, publicize, and make the cost of doing
nothing higher than the cost of doing right.
• Facing the hardest lobby of all. When Kennedy announced the Pfizer drug-pricing
deal, he praised the CEO for "putting public health ahead of his individual interests" — while the rest of the pharmaceutical industry, as Trump noted, was expected to
fall in line. The industry's trade group called importing foreign prices "a bad deal for
American patients." When the most powerful lobby in Washington unites against
you, that is usually a sign you are standing somewhere important.
These are not the priorities of a conventional Republican administration, or a conventional
Democratic one. They are the priorities of the consumer movement, which spent decades
asking both parties to confront the food industry's influence over its own regulators and
getting neither to do it.
The Rest of the Case
The Kennedy appointment is the centerpiece, but the surrounding record reinforces the
argument:
Drug pricing. On May 12, 2025, Trump signed an executive order, "Delivering Most
Favored-Nation Prescription Drug Pricing to American Patients," demanding that Americans
no longer pay the highest drug prices in the developed world. In July, he sent letters to
seventeen leading pharmaceutical manufacturers telling them to bring U.S. prices in line
with the lowest prices paid in comparable countries. On September 30, 2025, he
announced the first agreement, with Pfizer, granting every state Medicaid program access
to most-favored-nation prices, requiring deep discounts for patients buying directly, and
launching TrumpRx, a direct-to-consumer website where Americans can buy medicine at
discounted prices without insurance. By the end of 2025, the administration had struck
MFN deals covering, it says, roughly 90 percent of the drugs Americans use.
Price transparency. Trump's first-term hospital price transparency rule, requiring hospitals
to publish the actual prices they charge — survived ferocious industry litigation and
enforcement fights, and his second administration layered on further disclosure
requirements. Like Nader's Freedom of Information Act, it rests on a simple consumer
principle: the public's right to see the numbers.
The pattern is consistent: confrontation with concentrated industries, food,
pharmaceutical, medical, on behalf of the ordinary buyer, the patient, the parent.
The Answer: Impeachment, Not Alternatives
Here is the part that should trouble anyone who considers themselves a consumer
advocate, regardless of party. The electorate has just handed Democrats control of
Congress, and the response to the most aggressive consumer-protection agenda in
decades is not a counter-proposal, it is a removal effort.Articles of impeachment against
Kennedy were filed in December 2025 by Rep. Haley
Stevens of Michigan, with Rep. Eric Swalwell as an original cosponsor. Sen. Bernie Sanders
has explicitly called for Kennedy's impeachment; Rep. James Clyburn says he is open to it;
Sen. Angela Alsobrooks demands his removal; Gov. Andy Beshear, eyeing a presidential
run, wants him fired. The Associated Press reports that when the new Congress convenes
in January, Kennedy will be among the very first oversight targets, with senior lawmakers
suggesting impeachment. Impeachment resolutions against Kennedy, like those against
other cabinet members, stalled while Republicans led the House; now that the math has
changed, the threats are becoming plans.
Notice what is absent from the debate. Where is the Democratic plan to lower drug prices
by international comparison? The alternative food-safety program? The rival price
transparency scheme? Millions of voters who backed Trump because of the Kennedy wing
of his coalition, roughly four in ten parents tell pollsters they identify with the Make America
Healthy Again agenda, are being told the answer to cheaper medicine and cleaner food
labels is the impeachment of the man pursuing it. Not a single national Democratic figure
has answered the dye phase-out with legislation, the MFN deals with a pricing bill, or the
industry pressure campaign with a competing consumer agenda.
Ralph Nader understood this dynamic better than anyone. During his 2000 run, he watched
the institutional machinery try to bargain, pressure, and shame an inconvenient advocate
out of the way rather than engage his arguments. Twenty-five years later, the playbook
looks the same, except now the target holds an office, the advocate beside him holds the
presidency, and the weapon is not an editorial page but articles of impeachment. If the
consumer agenda were truly wrong on the merits, the remedy would be a better one. The
decision to fight it with removal instead says a great deal about whose interests feel
threatened, and it is not the shopper standing in the grocery aisle.
But the Nader test was always simple: does power fear you on the public's behalf, or does it
fund you? Ralph Nader earned his place in history because General Motors tried to destroy
him and failed. Robert F. Kennedy Jr. earned his place in this story by spending forty years
suing, investigating, and confronting the industries he challenged, and then by choosing,
unlike his old mentor in 2000, to enter the building rather than protest outside it. Trump's
contribution was the one Nader never received from either party: the keys. Now the fight
over whether those keys get taken away will tell us whether consumer protection in
America has finally found a permanent home, or must once again live outside the building,
in the streets.Robert F. Kennedy Jr. suspended his independent presidential campaign and endorsed
Donald Trump in August 2024, and was nominated on November 14, 2024 to serve as
Secretary of Health and Human Services, the first career public-interest environmental
litigator to hold the post. Sources for this article include FDA and White House
announcements, the Associated Press, ABC News, CNBC, NBC News, NPR, Reuters, Time,
USA Today, The Hill, and Consumer Reports.



